MPR provides drug monographs, drug news and e-prescribing service for healthcare professionals. We provides drug dosing, interactions, recalls and more for medical professionals.

View our rich drug database that contains concise drug information on more than 4,000 drugs and provides indication, dose, contraindications, precautions, interactions, adverse reactions ...

myCME: Earn FREE CME/CE within the MPR app. myCME provides relevant education that positively impacts clinical performance and patient outcomes. Medical Calculators: 100+ …

Ibuprofen prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and Ibuprofenside effects.

Prednisone Tablets are indicated for the following conditions: Endocrine Disorders. Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic ...

Jan 16, 2025 · Pharmaceutical drug news, medical and health articles for medical professionals. Learn about drug recalls, pharma label changes and the latest drug news on MPR.

1 day ago · The Food and Drug Administration (FDA) has approved Enhertu ® (fam-trastuzumab deruxtecan-nxki) for the treatment of adult patients with unresectable or metastatic hormone …

Dec 6, 2024 · The FDA is expected to decide on treatments for EBV-positive posttransplant lymphoproliferative disease, breast cancer, Barth syndrome, pain, and migraine.

Jan 9, 2025 · Medical and clinical practice guidelines news keeping medical professionals updated on recommendations, treatments and medical policies within their specific expertise.

Nov 4, 2024 · The Food and Drug Administration has approved Emrosi ™ (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions (papules …